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Objective: We analysed the variation in the outcome of inffainguinal bypass urgery between departments in a register 
for clinical audit to see if variation in case-mix influenced the results. 
Materials and Methods: The study was a retrospective analysis of 764 infrainguinal bypass operations performed from 
1988 to 1990 at six Swedish surgical departments. Results were assessed at 30 days and at 1 year postoperatively. 
Results: There was a significant variation (p < 0.01) in mortality and amputation rates both at 30 days and at 1 year and 
in patency rate at 30 days. There were also differences in case-mix. Differences were found in indication, location of distal 
anastomosis and graft type. Regression analysis found that mortality was influenced by age, diabetes and heart disease and 
patency rate by location of the distal anastomosis and graft type. When "hospital" was added as a variable in the regression 
analysis it was also found to be a significant indicator. 
Conclusion: Location of the distal anastomosis was the main factor in adjusting patency for case-mix. 
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Introduction 
Various systems for measuring outcome and quality 
are used by surgical departments. Patient outcome 
data are often used in the process of improving results. 
There is, however, a growing interest from financing 
organisations and from government departments in
knowing what results may be expected. 1 If compar- 
isons of the results and quality of individual depart- 
ments are to be performed, certain methodological 
problems arise: 
- -  the annual number of cases and especially compli- 
cations per department are often small, which leads to 
wide confidence intervals; 
- -  registration of patients and data may be 
incomplete; 2 
- -  the composition of patient (case-mix) may vary. 
The aim of the present investigation was to compare 
six Swedish vascular surgical departments in order to 
see whether there were differences regarding treat- 
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ment results and case-mix and to study if routinely 
available information on case-mix was sufficient to 
explain differences in outcome between hospitals. 
Infrainguinal bypass operations were chosen, being 
one of the most common and important procedures in 
vascular surgery. 
Methods 
From 1988 to 1990 all hospitals in Southern Sweden 
took part in the SWEDVASC register and six of those 
with the largest number of operations were chosen for 
this retrospective analysis. All infrainguinal bypass 
operations performed during these 3 years were 
included in the study. A total of 687 operations were 
reported to the register but further, unreported cases 
were found via administrative patient registers. The 
total number of operations amounted to 809. Forty- 
five patients records could not be found which is why 
the study was based on 764 operations. 
The vascular egister, SWEDVASC, records data on 
patients, operations and results at 30 days and at 1 
year with a total of 44 variables. 3 The surgeon in 
charge of the patient is responsible for collecting the 
data, which are sent to a central office for analysis. 
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Two surgeons, not affiliated to any of the six depart- 
ments, studied the patient records from the surgical, 
medical and orthopaedic departments. All variables 
were coded in the same manner as in the ordinary 
register without knowing what had previously been 
reported by the original surgeons. 
A subset of variables were used in the analysis. The 
variables were classified in two groups either measur- 
ing the outcome or used to describe the case-mix. The 
outcome variables were mortality, amputation and 
patency rates. Mortality and amputation could be 
determined exactly. Dates of death were obtained 
from the national Swedish population register. 
Patency was more difficult to define exactly from data 
in the records. Ankle brachial pressure index (ABI) 
was used, if recorded. Both pre- and postoperative 
registrations were found in 62% of cases. An increase 
of > 10% associated with symptomatic relief was 
taken as an indication of patency. Apart from that, we 
had to rely on statements in the notes made by the 
examining surgeons uch as palpable pulses and other 
observations. In 45 cases it was not possible from the 
clinical notes to determine with reasonable accuracy 
whether the graft was patent or not at 1 year. These 
grafts were considered ocduded. Secondary patency 
was accepted when only minor revisions, thrombect- 
omy or thrombolysis had been performed. If a new 
bypass, was performed, or a procedure of similar 
magnitude, the original bypass was considered a 
failure. 
Several other variables, called 'background varia- 
bles' were used to characterise the composition of the 
patient groups. These were age, sex, indication, 
location of distal anastomosis, graft material and the 
risk factors: diabetes, cerebrovascular disease and 
heart disease. Whether the operation was urgent or a 
redo procedure were also registered. All data were 
taken from the records and the description by the 
examining physician accepted. Coding of the indica- 
tion for surgery was sometimes problematic in so far 
as rest pain was not always clearly distinguishable 
from claudication. Continuous consumption of strong 
analgesics (dextropropoxyphene or stronger) was 
accepted as an indicator of severe ischaemia. The ABI 
was higher than 0.5 in 36%, 15% and 17% respectively 
in patients with claudication, rest pain and ulcer/ 
gangrene. The risk factors were defined as follows: 
'cerebrovascular disease' in patients with previous 
stroke, TIA. or subarachnoidal b eeding; evidence of 
coronary artery disease, valve disease and atrial 
fibrillation were regarded as 'cardiac disease'; diabetes 
mellitus was considered present if the patient medi- 
cated with either insulin or oral drugs. 
Statistical methods 
Data were stored and processed using the SPSS 
package. Frequencies were analysed with Chi-square. 
Multiple logistic regression analysis was applied to 
the total material of all cases together to determine 
which background variables had an influence on the 
outcome and odds ratios were calculated. 
Results 
The outcome for the patients at the six departments 
are shown in Table 1 There were significant differ- 
ences between the departments in mortality and 
amputation rates both at 30 days and at i year and in 
patency rates at 30 days (p< 0.01). Differences in 
patency rates at I year were not significant. There was 
a co-variation between mortality and amputation rate 
at 1 year. Thus, if the mortality was high at a certain 
department the same was the case with the amputa- 
tion rate. Similarly there was an inverse relationship 
between amputation rate and patency rate at i year. At 
30 days the corresponding comparisons did not show 
a clear co-variation. 
The case-mix compositions of the patient groups at 
the six departments, are shown in Table 2. There were 
highly significant differences in indication, location of 
distal anastomosis and graft type but not in the other 
variables. It is evident that the selection of patients 
and the operative technique varied greatly. There was 
an inverse relationship between the proportion of 
anastomosis to crural arteries and patency rates at 1 
year. 
To identify variables influencing the outcome, mul- 
tiple regression analysis was performed on all 
patients. All background variables were matched 
against outcome at 30 days and at i year (Table 3). The 
1 year mortality was influenced by age, diabetes and 
cardiac disease and amputation rate by distal anasto- 
mosis, graft material and indication (p < 0.01). In the 
analysis of patency rates a prognostic influence was 
found for distal anastomosis both at 30 days and at 1 
year. Of the remaining variables only graft type 
reached statistical significance in the analysis at i year. 
An interesting observation was that indication 
appeared to be an indicator of amputation rate and 
potency rate at either 30 days or at 1 year but not for 
both time points. When the variable 'hospital' was 
added to the regression analysis it was found to be a 
significant predictor of the i year mortality, and of the 
patency rate and the amputation rate both at 30 days 
and at 1 year. 
Eur J Vasc Endovasc Surg Vol 12, November 1996 
Case-mix and Outcome 46"1 
Table 1. Outcome of infrainguinal bypass surgery. 
Hospital 
Variable 1 2 3 4 5 6 Total 
No. of operations 85 83 117 
At 30 days 
Dead 
Without occlusion 5 3 2 
With occluded graft 4 2 2 
Alive with patent graft 50 68 104 
Amputations 16 2 3 
Mortality (%) 11 6 3 
Patency (%) 68 93 94 
Amputation rate (%) 19 2 3 
At I year 
Dead 
Without occlusion 23 12 9 
With ocduded graft 6 4 6 
Alive with patent graft 24 50 71 
Amputations 23 5 12 
Mortality (%) 34 19 13 
Patency (%) 52 79 75 
Amputation rate (%) 27 6 10 
189 175 115 764 
14 9 1 34 
1 9 
131 136 97 586 
13 15 4 53 
8 5 1 6 
83 86 87 85 
7 9 3 7 
52 34 13 140 
3 2 1 22 
77 81 68 371 
34 28 14 116 
29 20 12 21 
65 68 71 68 
18 16 12 15 
Discussion 
Many art icles have addressed  the prob lem that results  
are dependent  on the sever i ty  of the d isease and  
coexist ing r isk  factors. This has been repor ted  in 
vascu lar  surgery  4-6 and  in other  s i tuat ions.  7'8 In 
vascu lar  surgery  it is be l ieved  that, among others, 
indicat ion,  type  of operat ion,  and  r isk factors such as 
diabetes,  smoking,  cardiac and  cerebral  atherosclerosis  
are important .  In our  invest igat ion mor ta l i ty  was  
in f luenced by  factors re lated to the preoperat ive  
medica l  status of the pat ients  but  not  to the technical  
factors. Swed ish  hospi ta ls  all have wel l  def ined 
catchment  areas and  few pat ients  at tend other  hosp i -  
tals than the nearest  one. It is also h igh ly  un l ike ly  that 
there were major  di f ferences in the character ist ics of 
the popu la t ions  in the var ious  catchment  areas. 
Therefore dif ferent pol ic ies in select ing pat ients  for 
operat ion  could  be assumed to be the reason for the 
var iat ion  in mortal i ty.  However ,  we  d id  not  f ind 
dif ferences between hospi ta ls  in the background 
var iab les  for mortal i ty.  If the select ion process was  stil l  
Table 2. Background variables of patient groups. Number of cases (%). 
Hospital 
Variable 1 2 3 4 5 6 Total 
No. of operations 85 83 
Age, median 77 74 
Male sex (%) 39 (46) 52 (63) 
Diabetes 34 (40) 31 (37) 
Cardiac disease 50 (59) 53 (64) 
Cerebrovascular disease 14 (17) 9 (11) 
Emergency operation 4 (5) 8 (10) 
Redo procedure 25 (29) 11 (13) 
Indication 
Claudication 2 (2) 24 (29) 
Rest pain 26 (31) 21 (25) 
Ulcer/gangrene 46 (54) 28 (34) 
Other 11 (13) 10 (12) 
Distal anastomosis 
To popliteal arteries 41 (48) 64 (77) 
To crural arteries 44 (52) 19 (23) 
Graft 
Vein 74 (87) 52 (63) 
PTFE 11 (13) 30 (36) 
Other 1 (1) 
117 189 175 115 764 
75 74 74 73 
56 (48) 96 (51) 108 (62) 59 (51) 410 (54) 
41 (351 71 (38) 50 (29) 33 (29) 260 (34) 
50 (43) 99 (52) 86 (49) 42 (37) 380 (50) 
10 (9) 30 (16) 27 (15) 13 (11) 103 (14) 
4 (3) 20 (11) 23 (13) 7 (6) 66 (9) 
22 (19) 30 (16) 34 (19) 18 (16) 140 (18) 
27 (33) 6 (3) 39 (22) 10 (9) 108 (14) 
35 (30) 80 (42) 65 (37) 51 (44) 278 (36) 
50 (43) 77 (41) 55 (31) 37 (32) 293 (38) 
5 (4) 26 (14) 16 (9) 17 (15) 85 (11) 
90 (77) 129 (68) 87 (50) 60 (52) 471 (62) 
27 (23) 60 (32) 88 (50) 55 (48) 293 (38) 
32 (27) 115 (61) 133 (76) 90 (78) 496 (65) 
84 (72) 73 (39) 33 (19) 24 (21) 255 (33) 
1 (1) 1 (1) 9 (5) 1 (1) 13 (2) 
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Table 3. Odds ratios and 95% confidence intervals for mortality, amputation and patency rates at 30 days and I year. 
Mortality Amputation Patency 
Variable 30 days 1 year 30 days i year 30 days I year 
Age (<75 vs. >75 yr) 0.75 (0.52-1.08) 0.76 (0.62-0.93)** 0,88 (0.63-1.23) 0.87 
Sex (male vs. female) 0.98 (0.50-1.92) 0.88 (0.60-1.30) 1.11 (0.79-2.11) 1.42 
Diabetes (yes vs. no) 2.52 (1.30--4.92)** 1.83 (1.24-2.69)** 2.03 (1,08-3.82)* 0.99 
Cardiac (yes vs. no) 1.42 (0.72-2.83) 1.89 (1.29-2.76)*** 1.03 (0.55-1.95) 0.85 
CV-disease (yes vs. no) 1.70 (0.75-3.88) 1.49 (0.90-2.46) 2.23 (1.03-4.84)* 1.66 
Emergency vs. elective 0.23 (0.05-1.00) 1.05 (0.48-2.30) 2.82 (1.06-7.50)* 1.08 
Primary vs. sec. proc. 0.68 (0.25-1.89) 0.79 (0.44-1.41) 1.05 (0.45-2.47) 1.19 
Claud. vs. ulc/gangrene 0.40 (0.13-1.25) 0.66 (0.36-1.19) 0.81 (0.34-1.94) 0.48 
Synthetic vs. vein graft 6.64 (<0 - >10) 1,41 (0.67-2.96) 1.14 (0.60-2.19) 0.49 
Crural vs. fempop 1.72 (0.85-3.49) 1.03 (0,69-1.54) 3.18 (1.64-6.16)*** 3.75 
Hospital i vs. 6 1.82 (0.83-4.00) 1.66 (1.06-2.60)* 5.01 (2.24-3.41)** 2.05 
(0.68-1,10) 1.12 (0.91-1.39) 1.02 (0.87-1.03) 
(0.90-2.22) 0.85 (0.57-1.28) 1.00 (0.73-1.38) 
(0.63-1.57) 0.92 (0.61-1.38) 0.97 (0.70-1.35) 
(0.55-1.32) 1.15 (0.78-1.71) 0.91 (0.66-1.90) 
(0.92-3.03) 0.87 (0.49-1.52) 0.82 (0.52-1.28) 
(0.46-2.53) 0.97 (0.46-2.05) 0.77 (0.40-1.47) 
(0.65-2.18) 0.59 (0.35-1.02) 0.74 (0.47-1.17) 
(0.2A-~.97)* 2.09 (1,14-3.83)* 1.09 (0.70-1.45) 
(0.30--0.83)** 0.99 (0,62-1.58) 1.95 (1.12-3.40)* 
(2.34--6.00)*** 0.42 (0.28-0.64)*** 0.46 (0.39-0.64)*** 
(1.24-3.42)** 0.42 (0.27-0.68)"* 0.56 (0.38-43.85)** 
"p~005 
**p<0.01 
***p<0.001 
the explanation, our method of registration must have 
been too crude and a more detailed comparison using 
a cardiac index 9 may have improved the evaluation of 
the mortality figures. Other explanations are also 
possible as anaesthetic techniques and medical treat- 
ment in the perioperative period are of great impor- 
tance. Such factors are not registered in the SWED- 
VASC protocol because it was necessary to keep the 
data set simple. Thus we cannot decide which factor 
was the important cause of the variation in mortality 
between hospitals. However, it seems reasonable to 
include a cardiac index in future protocols. 
The patency rate was more dependent on factors 
related to surgical technique. The most important 
factor was the level of the distal anastomosis. 1° This is 
of course is mostly a function of how advanced the 
disease process it. Therefore it could be claimed that 
the choice of level is a part of the process of selecting 
patients for operation. If patients are chosen who need 
a bypass to crural arteries, inferior results have to be 
accepted. When we compared the six hospitals a clear 
correlation was found between the patency rate at 1 
year and the proportion of crural bypasses, but not for 
the other variables which were found to be significant 
in the regression analysis. There are probably other 
causes of occlusion than the variables registered by 
Swedvasc. These include antithrombotic medica- 
tionY '12 epidural anaesthesia, 13 quality of runoff, vein 
14 quality, technique of vein valve destruction, smok- 
10 15 ing, ' and surgeon. We conclude that patency rate is 
too multifactorial a variable to be comprehensively 
analysed in a clinical quality assessment register. If all 
possible factors were to be registered it would proba- 
bly lead to failing recruitment of cases and impaired 
data quality. 
The 1 year mortality and amputation rate at the 
hospitals varied together. Similarly there was an 
inverse covariation between patency rate and amputa- 
tion rate. This may occur if the important background 
variables are similar and could have been the cause of 
the relationship between patency rate and amputation 
rate in this investigation. The important background 
variables differed for mortality and amputation rate 
and the covariation found might instead have been 
caused by the high risk of death after major amputa- 
tion, which has been reported previously. At 30 days 
no clear correlation was found in either of the two 
pairs of outcome variables. A probable reason for this 
is that the decision to proceed with an amputation 
after a failed operation may be postponed to a 
timepoint beyond 30 days. Therefore we believe that 
the amputation rate is an inappropriate outcome 
measurement at 30 days and should be measured 
later. 
Another question to address is whether the outcome 
measurements should be adjusted for important varia- 
bles. Such variables must correlate well to outcome 
not only in scientific investigations but also in large 
scale registration of patients in clinical routine. If such 
variables could be found it would help the depart- 
ments in their search for ways to improve the results. 
In this register location of the distal anastomosis was 
such a variable regarding both patency rate and 
amputation rate. 
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